GSK P/E Ratio Analysis
Updated 299h ago·SEC filings & market data
Key Takeaway
The P/E ratio of 21.5x means investors pay $21.50 for every $1 of the company's annual earnings, a common measure of how expensive a stock is relative to its profitability.
Sector Performance
45th percentileGSK
21.5x
Sector Median
23.1x
Sector Avg
33.8x
Prior Period
17.7x(Jun 2026)
Deep Analysis
The P/E ratio of 21.5x means investors pay $21.50 for every $1 of the company's annual earnings, a common measure of how expensive a stock is relative to its profitability.
Compared to sector peers, this sits below the exact median of 23.3x, placing GSK in the 45th percentile, so it is slightly cheaper than half of its peer group. The trend data is N/A, with year-over-year change N/A and quarter-over-quarter change N/A, so no directional signal is available from this metric. The level alone offers a mild valuation advantage over the peer median, but without trend information, there is no evidence of improving or deteriorating valuation pressure. This modestly below-median multiple does not create a clear risk or opportunity; it is consistent with a stock that is neither overpriced nor a bargain relative to its sector. Therefore, the metric supports the overall NEUTRAL verdict, as the P/E ratio indicates fair valuation without a compelling edge.
Frequently Asked Questions
What does the P/E Ratio tell investors about GSK?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are GSK's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: CMCSA (7.8x), EG (7.8x), CHRD (7.7x), OXY (7.4x), THC (7.3x).
Learn More About P/E Ratio
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master GSK's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full GSK research report →GSK
21.5x
Sector Median
23.1x
Sector Avg
33.8x
How GSK's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.